Free Trial
EPA:DIM

Sartorius Stedim Biotech (DIM) Stock Price, News & Analysis

Sartorius Stedim Biotech logo
€192.00
+8.70 (+4.75%)
(As of 11/1/2024 ET)

About Sartorius Stedim Biotech Stock (EPA:DIM)

Key Stats

Today's Range
€180.80
€193.70
50-Day Range
€170.35
€211.90
52-Week Range
N/A
Volume
71,137 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

DIM Stock News Headlines

Musk Says ‘Dollar Will Be Worth Nothing…’
Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…
Jefferies Sticks to Their Hold Rating for Sartorius (0NIR)
Kepler Capital Remains a Sell on Sartorius (0NIR)
RBC Capital Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)
See More Headlines

DIM Stock Analysis - Frequently Asked Questions

Sartorius Stedim Biotech's stock was trading at €239.50 at the beginning of the year. Since then, DIM stock has decreased by 19.8% and is now trading at €192.00.
View the best growth stocks for 2024 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Corbus Pharmaceuticals (CRBP), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and C3.ai (AI).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
10,493
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (EPA:DIM) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners